Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Last Updated: September 28, 2022

Litigation Details for Horatio Washington Depot Technologies LLC v. Tolmar, Inc. (D. Del. 2017)

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

Small Molecule Drugs cited in Horatio Washington Depot Technologies LLC v. Tolmar, Inc.
The small molecule drug covered by the patents cited in this case is See Plans and Pricing .

Details for Horatio Washington Depot Technologies LLC v. Tolmar, Inc. (D. Del. 2017)

Date Filed Document No. Description Snippet Link To Document
2018-12-25 102 Horatio's U.S. Patent Nos. 5,932,547("the '547 patent"), 6,124,261 ("the '…x27;261 patent"), and 6,235,712("the '712 patent"). (D.I. 1) The patents- in-suit describe…formulations. ('547 patent, cl. 1;'261 patent, cl. 3,4;'712 patent, cl. 1, 8) According …x27;547 patent, claims 3 and 4 ofthe '261 patent, and claims 1 and 8 ofthe '712 patent. term …quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which the External link to document
2019-08-27 146 Order - -Memorandum and Order infringement of U.S. Patent Nos. 5,932,547 (“the ‘547 patent”), 6,124,261 (“the ‘261 patent”), and 6,235,7126,235,712 (“the ‘712 patent”). (D.I. 1) The patents-in-suit describe stable non- aqueous formulations that …example, to treat prostatic cancer. (‘547 patent, 1 The patents share substantially identical specifications…2:29-46) The ‘547 and ‘261 patents claim formulations while the ‘712 patent claims methods for making… claim 4 of the ‘547 patent and to claims 4, 8-10, and 12-15 of the ‘712 patent. (D.I. 119) The parties External link to document
2017-08-03 3 Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,932,547; 6,124,261; 6,235,712;. … 2017 4 June 2019 1:17-cv-01086 830 Patent Plaintiff District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.